Metarrestin, a perinucleolar compartment inhibitor, effectively suppresses metastasis

Journal: Science Translational Medicine

Published: 2018-05-16

DOI: 10.1126/scitranslmed.aap8307

Affiliations: 18

Authors: 48

Go to article
Institutions FC
Department of Cell and Molecular Biology (CMB), NU, United States of America (USA) 0.29
NIH NCI Thoracic and Gastrointestinal Malignancies Branch (TGIB), United States of America (USA) 0.13
NIH National Center for Advancing Translational Sciences (NCATS), United States of America (USA) 0.10
NIH NCI Chemical Genomics Center (NCGC), United States of America (USA) 0.10
KU Specialized Chemistry Center (SCC), United States of America (USA) 0.06
Frederick National Laboratory for Cancer Research (FNLCR), United States of America (USA) 0.06
Department of Biochemistry and Molecular Genetics, NU, United States of America (USA) 0.04
Tufts Department of Developmental, Molecular and Chemical Biology (DMCB), United States of America (USA) 0.04
Cancer Research Technology Program (CRTP), FNLCR, United States of America (USA) 0.04
Robert H. Lurie Comprehensive Cancer Center, NU, United States of America (USA) 0.02
Center for Developmental Therapeutics, NU, United States of America (USA) 0.02
NIH NCI Laboratory of Pathology, United States of America (USA) 0.02
Yale Department of Molecular Biophysics and Biochemistry (MBB), United States of America (USA) 0.01
Yale Department of Genetics, United States of America (USA) 0.01
Yale Department of Therapeutic Radiology, United States of America (USA) 0.01
Department of Human Genetics, Emory University, United States of America (USA) 0.01
Graduate Division of Biological and Biomedical Sciences (GDBBS), Emory University, United States of America (USA) 0.01

Return